martes, 17 de marzo de 2020

Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy | Cancer Discovery

Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy | Cancer Discovery



Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy

Tanner M. JohannsChristopher A. MillerIan G. DorwardChristina TsienEdward ChangArie PerryRavindra UppaluriCole FergusonRobert E. SchmidtSonika DahiyaGeorge AnsstasElaine R. Mardis and Gavin P. Dunn

No hay comentarios:

Publicar un comentario